Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE